Open AccessSevere hepatic cytolysis: incidence and risk factors in patients treated by antiretroviral combinations Aquitaine Cohort, France, 1996-1998
Author(s) -
Marianne Savès,
Stéphanie Vandentorren,
V. Daucourt,
Catherine Marimoutou,
M. Dupon,
Patrice Couzigou,
N. Bernard,
P. Mercié,
François Dabis
Publication year - 1999
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/00002030-199912030-00002
Subject(s) - medicine , gastroenterology , hazard ratio , confidence interval , cohort , cumulative incidence , incidence (geometry) , cohort study , cytolysis , reverse transcriptase inhibitor , alanine transaminase , immunology , sida , human immunodeficiency virus (hiv) , viral disease , biology , optics , biochemistry , cytotoxic t cell , in vitro , physics
To study hepatic cytolysis in patients treated by highly active antiretroviral therapy (HAART) with protease inhibitor or with two nucleoside reverse transcriptase inhibitors (NRTIs).